市場調査レポート - 119574
世界の体外照射療法市場
Market Agent: 2011 GLOBAL MARKETS FOR EXTERNAL RADIATION THERAPY
発行
Life Science Intelligence, Inc.
出版日
2011年05月01日
ページ情報
英文
価格
世界の体外照射療法市場
Market Agent: 2011 GLOBAL MARKETS FOR EXTERNAL RADIATION THERAPY
出版日: 2011年05月01日
ページ情報: 英文
当サービスは、世界の体外照射療法市場に関する包括的市場インテリジェンスソリューションで、高品質で詳細な最新データを提供しています。
第1章 既存の技術と特徴と新興技術
既存技術の特徴
既存技術の課題
適合性
無酸素組織
経済的要因
償還と国の政策や取組み
システム価格と関連費用
世界経済
第2章 米国の体外照射療法市場
市場予測:2007〜2013年
サプライヤーシェア:2008年
線形加速器およびガンマ線装置市場の影響因子
米国の体外照射療法:線形加速器およびガンマ線装置:2007〜2013年
線形加速器およびガンマ線装置における米国のシェア:2008年
米国のシステム別市場予測:2007〜2013年
線形加速器およびガンマ線装置:2008年および2013年
不況の影響:線形加速器およびガンマ線装置
体外照射療法とSRS市場:2007〜2013年
体外照射療法とSRS市場の影響因子:2007〜2013年
用途別市場予測:2007〜2013年
SRSおよび体外照射療法装置:2008年および2013年
不況の影響:SRS装置
定位的放射線治療:米国患者人数:2007〜2013年
定位的放射線治療:米国タイプ別患者動向:2007〜2013年
頭蓋外定位的放射線治療:米国患者人数:2007〜2013年
定位的放射線治療:米国の処置件数:2007〜2013年
定位的放射線治療:米国のタイプ別処置件数:2007〜2013年
不況の影響:頭蓋外定位的放射線治療
体外照射療法で治療した乳癌・肺癌・前立腺癌患者数:2007〜2013年
陽子線治療:米国市場予測:2007〜2013年
陽子線治療装置:米国サプライヤーシェア:2008年
陽子線治療:患者動向:2007〜2013年
陽子線治療:米国処置件数:2007〜2013年
第3章 米国以外の体外照射療法市場
第4章 合併・買収・提携
第5章 新興企業
Abstract
“2011 GLOBAL MARKETS FOR EXTERNAL RADIATION THERAPY” is a comprehensive, total
market intelligence solution designed for senior executives who are looking
for:
High quality, granular, deeply segmented data
Access to senior LSI analysts to conduct proprietary modeling and custom
market simulations
Access to useable source data for in-house customization and adoption of
market models
This product is a complete market intelligence solution.
The deliverables include:
Initial report with most recent data available (PDF and Excel)
Extensive access to senior LSI analyst for proprietary add-on analysis
Online platform making the data useable and interactive
About Life Science Intelligence
Life Science Intelligence (LSI) delivers high quality market reports, market
agents, procedure databases, company databases, online partnering events, and
custom consulting services to medical technology executives, investors, and
entrepreneurs. LSI produces its own information products and partners with
select top-tier information companies to distribute their products.
Table of Contents
1. ESTABLISHED AND EMERGING TECHNOLOGIES
1.1. Features of Established Technologies
1.2. Challenges for Established Technologies
1.2.1. Conformality
1.2.2. Anoxic Tissues
1.2.2.1. Economic Factors
1.2.2.1.1. Reimbursement and National Policies and Initiatives
1.2.2.1.2. System Prices & Associated Costs
1.2.2.1.3. The Global Economy
Exhibit 1-1: External Radiation Therapy by Type
Exhibit 1-2: Advantages and Disadvantages of External Radiation Therapy
Systems
Exhibit 1-3: Features of Linear Accelerator and Gamma-Ray Systems Used for
External Radiation Therapy and SRS
Exhibit 1-4: Features of Particle Therapy Centers
Exhibit 1-5: Challenges Associated with Available Technologies
Exhibit 1-6: Established and Emerging Technologies
2. U.S. MARKETS FOR EXTERNAL RADIATION THERAPY
Exhibit 2-1: External Radiation Therapy, U.S. Market Forecast, 2007-2013
Exhibit 2-2: External Radiation Therapy, Supplier Shares, 2008
Exhibit 2-3: Factors Influencing the U.S. Market for Linear Accelerator &
Gamma-Ray Systems from 2007-2013
Exhibit 2-4: U.S. External Radiation Therapy, Linear Accelerators &
Gamma-Ray Systems, 2007-2013
Exhibit 2-5: Linear Accelerator & Gamma-Ray Systems, U.S. Shares, 2008
Exhibit 2-6: U.S. Market Forecast by Type of System, Linear Accelerator
and Gamma-Ray Systems, 2007-2013
Exhibit 2-7: Linear Accelerator and Gamma-Ray Systems, 2008 & 2013
Exhibit 2-8: Impact of the Recession: Gamma-Ray Systems and Linear
Accelerators, 2007-2013
Exhibit 2-9: Factors Influencing the U.S. Market for External Radiation
Therapy and SRS from 2007-2013
Exhibit 2-10: External Radiation Therapy, U.S. Market Forecast by
Application, 2007-2013
Exhibit 2-11: SRS and External Radiation Systems, 2008 & 2013
Exhibit 2-12: Impact of the Recession: SRS Systems, 2007-2013
Exhibit 2-13: Stereotactic Radiosurgery - U.S. Patient Volumes, 2007-2013
Exhibit 2-14: Stereotactic Radiosurgery - U.S. Patient Volumes by Type,
2007-2013
Exhibit 2-15: Stereotactic Radiosurgery - Utilization by Patient Type,
2007-2013
Exhibit 2-16: Extracranial Stereotactic Radiosurgery - U.S. Patient
Volumes, 2007-2013
Exhibit 2-17: Stereotactic Radiosurgery - U.S. Procedure Volumes, 2007-2013
Exhibit 2-18: Stereotactic Radiosurgery - U.S. Procedures by Type,
2007-2013
Exhibit 2-19: Stereotactic Radiosurgery - Utilization by Procedure,
2007-2013
Exhibit 2-20: Extracranial Stereotactic Radiosurgery - U.S. Procedure
Volumes, 2007-2013
Exhibit 2-21: Impact of the Recession: External Radiation Therapy Systems,
2007-2013.
Exhibit 2-22: New Cancer Cases in the U.S by Anatomical Location, 2007-2013
Exhibit 2-23: Breast, Lung and Prostate Patients Treated with External
Radiation Therapy in the U.S., 2007-2013
Exhibit 2-24: Other Patients Treated with External Radiation Therapy,
2007-2013
Exhibit 2-25: External Radiation Therapy in the U.S., Breast, Lung, and
Prostate Procedures, 2007-2013
Exhibit 2-26: Other External Radiation Therapy Procedures in the U.S.,
2007-2013
Exhibit 2-27: Factors Influencing the U.S. Market for Proton Therapy,
2007-2013
Exhibit 2-28: Proton Therapy, U.S. Market Forecast, 2007-2013
Exhibit 2-29: Proton Therapy Systems, U.S. Supplier Shares in 2008
Exhibit 2-30: Proton Therapy, U.S. Patient Volumes, 2007-2013
Exhibit 2-31: Proton Therapy, U.S. Procedure Volumes, 2007-2013
3. OUS MARKETS FOR EXTERNAL RADIATION THERAPY
Exhibit 3-1: External Radiation Therapy, OUS Market Forecast, 2007-2013
Exhibit 3-2: OUS External Radiation Therapy, Supplier Shares, 2008
Exhibit 3-3: Factors Influencing the OUS Market for Linear Accelerator &
Gamma-Ray Systems from 2007-2013
Exhibit 3-4: External Radiation Therapy in Europe, Linear Accelerator &
Gamma-Ray Systems, 2007-2013
Exhibit 3-5: Linear Accelerator & Gamma-Ray Systems, European Shares in
2008
Exhibit 3-6: European Market Forecast by Type of System, Linear
Accelerator and Gamma-Ray Systems, 2007-2013
Exhibit 3-7: Linear Accelerator and Gamma-Ray Systems in Europe, 2008 &
2013
Exhibit 3-8: AP & ROW External Radiation Therapy, Linear Accelerator &
Gamma-Ray Systems, 2007-2013
Exhibit 3-9: Linear Accelerator & Gamma-Ray Systems, AP & ROW Shares, 2008
Exhibit 3-10: AP & ROW Market Forecast by Type of System, Gamma-Ray &
Linear Accelerator Systems, 2007-2013
Exhibit 3-11: Gamma-Ray & Linear Accelerator Systems in AP&ROW, 2008 & 2013
Exhibit 3-12: Factors Influencing the OUS Market for External Radiation
Therapy and SRS from 2007-2013
Exhibit 3-13: External Radiation Therapy, European Market Forecast by
Application, 2007-2013
Exhibit 3-14: SRS and External Radiation Systems in Europe, 2008 & 2013
Exhibit 3-15: Stereotactic Radiosurgery - European Patient Volumes,
2007-2013
Exhibit 3-16: Stereotactic Radiosurgery - European Patient Volumes by
Type, 2007-2013
Exhibit 3-17: Stereotactic Radiosurgery - Utilization by Patient Type in
Europe, 2007-2013
Exhibit 3-18: Extracranial Stereotactic Radiosurgery - European Patient
Volumes, 2007-2013
Exhibit 3-19: Stereotactic Radiosurgery - European Procedure Volumes,
2007-2013
Exhibit 3-20: Stereotactic Radiosurgery - European Procedures by Type,
2007-2013
Exhibit 3-21: Stereotactic Radiosurgery in Europe - Utilization by
Procedure, 2007-2013
Exhibit 3-22: Extracranial Stereotactic Radiosurgery - European Procedure
Volumes, 2007-2013
Exhibit 3-23: Breast, Lung and Prostate Patients Treated with Radiation
Therapy in Europe, 2007-2013
Exhibit 3-24: Other Patients Treated with External Radiation Therapy in
Europe, 2007-2013
Exhibit 3-25: External Radiation Therapy in Europe, Breast, Lung, and
Prostate Procedures, 2007-2013
Exhibit 3-26: Other External Radiation Therapy Procedures in Europe,
2007-2013
Exhibit 3-27: External Radiation Therapy, AP & ROW Market Forecast by
Application, 2007-2013
Exhibit 3-28: Stereotactic Radiosurgery - AP & ROW Patient Volumes,
2007-2013
Exhibit 3-29: Stereotactic Radiosurgery - AP & ROW Patient Volumes by
Type, 2007-2013
Exhibit 3-30: Stereotactic Radiosurgery - AP & ROW Utilization by Type of
Patients, 2007-2013
Exhibit 3-31: Stereotactic Radiosurgery - AP & ROW Procedure Volumes,
2007-2013
Exhibit 3-32: Stereotactic Radiosurgery - AP & ROW Procedures by Type,
2007-2013
Exhibit 3-33: Breast, Lung and Prostate Patients Treated with Radiation
Therapy in AP & ROW Countries, 2007-2013
Exhibit 3-34: Other Patients Treated with External Radiation Therapy in AP
& ROW Countries, 2007-2013
Exhibit 3-35: External Radiation Therapy in AP & ROW Countries, Breast,
Lung, and Prostate Procedures, 2007-2013
Exhibit 3-36: Other External Radiation Therapy Procedures in AP & ROW
Countries, 2007-2013
Exhibit 3-37: Factors Influencing the OUS Market for Particle Therapy,
2007-2013
Exhibit 3-38: Particle Therapy, European Market Forecast, 2007-2013
Exhibit 3-39: Particle Therapy in Europe by Type, 2007-2013
Exhibit 3-40: Particle Therapy Systems, European Supplier Shares in 2008
Exhibit 3-41: Particle Therapy, European Patient Volumes, 2007-2013
Exhibit 3-42: Particle Therapy, AP & ROW Market Forecast, 2007-2013
Exhibit 3-43: Particle Therapy in Europe by Type, 2007-2013
Exhibit 3-44: Particle Therapy Systems, AP & ROW Supplier Shares in 2008
Exhibit 3-45: Particle Therapy, AP & ROW Patient Volumes, 2007-2013
4. MERGERS, ACQUISITIONS, AND PARTNERSHIPS
5. EMERGING COMPANIES
「世界の体外照射療法市場 」は2011年05月01日にライフサイエンス・インテリジェンス より発行されました。 当レポートは税抜¥633,425より販売しています。